EMEA-000452-PIP02-10-M06

Key facts

Invented name
  • Cialis
  • Adcirca (previously Tadalafil Lilly)
  • Adcirca
Active substance
tadalafil
Therapeutic area
Cardiovascular diseases
Decision number
P/0376/2020
PIP number
EMEA-000452-PIP02-10-M06
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral suspension
Condition(s) / indication(s)
Treatment of pulmonary arterial hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Eli Lilly & Company Limited

E-mail: eu_paediatric@lilly.com 
Tel. +44 (0)1276 483000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
57 ratings
54 ratings
64 ratings
47 ratings